Report of Foreign Issuer (6-k)
June 01 2020 - 6:35AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE
ACT OF 1934
For the month of June 2020
Commission file number: 001-38775
ITAMAR MEDICAL LTD.
(Name of registrant)
9 Halamish Street, Caesarea 3088900,
Israel
(Address of principal executive office)
_____________________
Indicate by
check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form
40-F ¨
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
____________________
EXPLANATORY NOTE
Itamar Medical Ltd.
hereby furnishes its investors presentation, which is attached to this Form 6-K as Exhibit 99.1.
Exhibits
Exhibit Number
|
Description
|
99.1
|
Itamar Medical Ltd., investors presentation, June 1,
2020.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
ITAMAR MEDICAL LTD.
|
|
|
|
|
|
By: /s/ Shy Basson
|
|
Shy Basson
Chief Financial Officer
|
Date: June 1, 2020
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Apr 2023 to Apr 2024